Yuhan Corp
Saeyoung Lee currently serves as Executive Director of the Medical Department at Yuhan Corporation since February 2021, while also holding the position of Senior Medical Advisor at Lilly Korea since January 2014, with a focus on oncology. Prior experience includes roles as Senior Medical Advisor at Eli Lilly and Company, where responsibilities encompassed various therapeutic areas including oncology, Alzheimer’s disease, and pain management, as well as being a staff physician at Miz Medi Hospital and SAM Anyang Hospital. Saeyoung's educational background includes a Master of Public Health (MPH) and a PhD in Science for Aging from Yonsei University, along with a Doctor of Medicine (MD) from Ewha Womans University.
This person is not in any teams
Yuhan Corp
1 followers
Yuhan Corporation is a Korea-based company mainly engaged in the manufacturing and sale of pharmaceuticals. Along with its subsidiaries, the Company operates its business through three segments. The Pharmaceutical segment is engaged in the production and sale of prescription drugs including anti-inflammatory drugs, as well as the non-prescription drugs such as drugs for hepatitis, diabetes, and hypertension. The Life and Health segment is involved in production and sale of household goods and animal healthcare (AHC) products, including bleach, antibacterial agents. The Overseas Business segment is supply raw drugs which manufactured by Yuhan Chemical Inc. to domestic and overseas markets. The Company distributes its products within the domestic market and to overseas markets, including Europe, Asia and United States.